Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test

This document is a response-to-comments notice for the MolDX Breast Cancer Index (BCI) Gene Expression Test related to LCD L37794 and provides administrative dates (comment period and effective date). The provided excerpt does not include specific clinical coverage indications, limitations, frequency limits, or required documentation for claims; consult the full LCD L37794 for actionable coverage criteria. Manual review of the final LCD and associated MolDX materials is required to extract definitive coverage rules.

"This document is a response to public comments on MolDX: Breast Cancer Index (BCI) Gene Expression Test Local Coverage Determination (LCD L37794); the excerpt contains no clinical coverage criteria."

Sign up to see full coverage criteria, indications, and limitations.